Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Chulalongkorn University hospital in South East Asia migrates to 3D Brachytherap

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse...

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK...

Teleradiology provider Medica Group has agreed to integrate Axon...

Nucletron, the world leader in brachytherapy, announced that the third major University Hospital in Asia has migrated their brachytherapy program from basic 2D treatment planning to advanced 3D treatment planning, using the latest brachytherapy solutions from Nucletron.

The Chulalongkorn University Hospital in Bangkok/Thailand treated their first gynecologic patient last week, using their newly acquired microSelectron® Digital remote afterloader, Oncentra® Brachy 3D brachytherapy treatment planning solution, and a range of Nucletron’s CT-MR GYN applicators. Nucletron helped the hospital to perform the treatment planning using MRI information fused into CT images.

Dr. Chonlakiet, Radiation Therapist at the Chulalongkorn Hospital says, It is an exciting experience to have MRI assisted brachytherapy with the latest advanced 3 D treatment planning for our patients.

This makes the Chulalongkorn Hospital the third University Hospital that has introduced Nucletron’s advanced treatment solutions for patients in Asia. Last year, the National University Hospital in Singapore also migrated their brachytherapy program from 2D treatment planning to 3D treatment planning, allowing them to assess the dose delivered to the target and the critical organs more accurately.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK Clinical Reporting

Teleradiology provider Medica Group has agreed to integrate Axon...

Sutter Health Integrates AI Decision Support in Epic EHR

Sutter Health is integrating artificial intelligence-powered decision support technology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »